![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: VEPH1 |
Gene summary for VEPH1 |
![]() |
Gene information | Species | Human | Gene symbol | VEPH1 | Gene ID | 79674 |
Gene name | ventricular zone expressed PH domain containing 1 | |
Gene Alias | MELT | |
Cytomap | 3q25.31-q25.32 | |
Gene Type | protein-coding | GO ID | GO:0007154 | UniProtAcc | Q14D04 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
79674 | VEPH1 | RNA-P10T2-P10T2-2 | Human | Lung | AAH | 2.98e-05 | 5.44e-01 | -0.1406 |
79674 | VEPH1 | RNA-P25T1-P25T1-1 | Human | Lung | AIS | 1.79e-13 | 8.26e-01 | -0.2116 |
79674 | VEPH1 | RNA-P25T1-P25T1-2 | Human | Lung | AIS | 7.95e-10 | 8.16e-01 | -0.1941 |
79674 | VEPH1 | RNA-P25T1-P25T1-3 | Human | Lung | AIS | 2.55e-08 | 8.28e-01 | -0.2107 |
79674 | VEPH1 | RNA-P25T1-P25T1-4 | Human | Lung | AIS | 1.29e-17 | 9.52e-01 | -0.2119 |
79674 | VEPH1 | RNA-P6T1-P6T1-3 | Human | Lung | MIAC | 4.36e-02 | -2.96e-01 | -0.0296 |
79674 | VEPH1 | RNA-P6T2-P6T2-1 | Human | Lung | IAC | 1.51e-14 | 2.18e-01 | -0.0166 |
79674 | VEPH1 | RNA-P6T2-P6T2-2 | Human | Lung | IAC | 6.25e-14 | 1.92e-01 | -0.0132 |
79674 | VEPH1 | RNA-P6T2-P6T2-3 | Human | Lung | IAC | 5.59e-18 | 1.86e-01 | -0.013 |
79674 | VEPH1 | RNA-P6T2-P6T2-4 | Human | Lung | IAC | 5.55e-13 | 3.01e-01 | -0.0121 |
79674 | VEPH1 | RNA-P7T1-P7T1-1 | Human | Lung | AIS | 3.51e-04 | 2.62e-02 | -0.0961 |
79674 | VEPH1 | RNA-P7T1-P7T1-3 | Human | Lung | AIS | 1.59e-03 | 3.73e-02 | -0.0822 |
79674 | VEPH1 | RNA-P7T1-P7T1-4 | Human | Lung | AIS | 2.88e-02 | -1.33e-01 | -0.0809 |
79674 | VEPH1 | RNA-P8T2-P8T2-3 | Human | Lung | AIS | 2.26e-04 | 3.84e-01 | -0.1284 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Lung | ![]() | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ | ||
IAC: Invasive lung adenocarcinoma | ||
MIA: Minimally invasive adenocarcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00715594 | Lung | IAC | response to transforming growth factor beta | 60/2061 | 256/18723 | 9.50e-09 | 1.25e-06 | 60 |
GO:00715604 | Lung | IAC | cellular response to transforming growth factor beta stimulus | 57/2061 | 250/18723 | 6.17e-08 | 6.54e-06 | 57 |
GO:00071794 | Lung | IAC | transforming growth factor beta receptor signaling pathway | 45/2061 | 198/18723 | 1.60e-06 | 7.93e-05 | 45 |
GO:00071785 | Lung | IAC | transmembrane receptor protein serine/threonine kinase signaling pathway | 60/2061 | 355/18723 | 4.82e-04 | 7.03e-03 | 60 |
GO:19038444 | Lung | IAC | regulation of cellular response to transforming growth factor beta stimulus | 27/2061 | 131/18723 | 9.41e-04 | 1.14e-02 | 27 |
GO:00170153 | Lung | IAC | regulation of transforming growth factor beta receptor signaling pathway | 26/2061 | 128/18723 | 1.45e-03 | 1.55e-02 | 26 |
GO:0030512 | Lung | IAC | negative regulation of transforming growth factor beta receptor signaling pathway | 18/2061 | 81/18723 | 2.68e-03 | 2.46e-02 | 18 |
GO:007155912 | Lung | AIS | response to transforming growth factor beta | 51/1849 | 256/18723 | 8.45e-07 | 6.08e-05 | 51 |
GO:007156012 | Lung | AIS | cellular response to transforming growth factor beta stimulus | 48/1849 | 250/18723 | 5.13e-06 | 2.47e-04 | 48 |
GO:000717912 | Lung | AIS | transforming growth factor beta receptor signaling pathway | 39/1849 | 198/18723 | 2.08e-05 | 7.12e-04 | 39 |
GO:190384412 | Lung | AIS | regulation of cellular response to transforming growth factor beta stimulus | 25/1849 | 131/18723 | 9.61e-04 | 1.27e-02 | 25 |
GO:000717812 | Lung | AIS | transmembrane receptor protein serine/threonine kinase signaling pathway | 53/1849 | 355/18723 | 1.51e-03 | 1.82e-02 | 53 |
GO:001701512 | Lung | AIS | regulation of transforming growth factor beta receptor signaling pathway | 24/1849 | 128/18723 | 1.55e-03 | 1.82e-02 | 24 |
GO:00305121 | Lung | AIS | negative regulation of transforming growth factor beta receptor signaling pathway | 17/1849 | 81/18723 | 2.09e-03 | 2.28e-02 | 17 |
GO:0090101 | Lung | AIS | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 23/1849 | 131/18723 | 4.54e-03 | 4.00e-02 | 23 |
GO:007155922 | Lung | MIAC | response to transforming growth factor beta | 28/967 | 256/18723 | 1.51e-04 | 5.95e-03 | 28 |
GO:007156022 | Lung | MIAC | cellular response to transforming growth factor beta stimulus | 26/967 | 250/18723 | 5.59e-04 | 1.42e-02 | 26 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
VEPH1 | SNV | Missense_Mutation | c.2406N>T | p.Lys802Asn | p.K802N | Q14D04 | protein_coding | deleterious(0) | possibly_damaging(0.483) | TCGA-BR-6452-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
VEPH1 | SNV | Missense_Mutation | rs532806977 | c.279N>G | p.Asn93Lys | p.N93K | Q14D04 | protein_coding | tolerated(0.05) | benign(0.251) | TCGA-BR-7716-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
VEPH1 | SNV | Missense_Mutation | c.1590G>T | p.Gln530His | p.Q530H | Q14D04 | protein_coding | tolerated(0.2) | benign(0.179) | TCGA-BR-8487-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
VEPH1 | SNV | Missense_Mutation | c.2245N>A | p.Leu749Met | p.L749M | Q14D04 | protein_coding | deleterious(0.02) | probably_damaging(0.981) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR | |
VEPH1 | SNV | Missense_Mutation | novel | c.2126N>A | p.Thr709Asn | p.T709N | Q14D04 | protein_coding | deleterious(0.02) | benign(0.031) | TCGA-CG-4460-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | capecitabine | PD |
VEPH1 | SNV | Missense_Mutation | rs751210034 | c.217N>A | p.Glu73Lys | p.E73K | Q14D04 | protein_coding | tolerated(0.53) | benign(0.001) | TCGA-CG-5722-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
VEPH1 | SNV | Missense_Mutation | novel | c.574N>A | p.Gln192Lys | p.Q192K | Q14D04 | protein_coding | tolerated(0.07) | benign(0.112) | TCGA-D7-A6EZ-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD |
VEPH1 | SNV | Missense_Mutation | rs151166199 | c.2215N>T | p.Arg739Cys | p.R739C | Q14D04 | protein_coding | deleterious(0) | probably_damaging(0.94) | TCGA-IN-A6RJ-01 | Stomach | stomach adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
VEPH1 | SNV | Missense_Mutation | c.1727N>A | p.Thr576Asn | p.T576N | Q14D04 | protein_coding | deleterious(0.01) | possibly_damaging(0.791) | TCGA-VQ-A8P2-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unspecific | Complete Response | ||
VEPH1 | insertion | Frame_Shift_Ins | novel | c.371_372insC | p.Val125SerfsTer26 | p.V125Sfs*26 | Q14D04 | protein_coding | TCGA-BR-4201-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | cisplatin | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |